Primary care providers should prescribe aspirin to prevent cardiovascular disease based on benefit−risk ratio, not age

Recent guidelines restricted aspirin (ASA) in primary prevention of cardiovascular disease (CVD) to patients <70 years old and more recent guidance to <60. In the most comprehensive prior meta-analysis, the Antithrombotic Trialists Collaboration reported a significant 12% reduction in CVD with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyungmann, Hennekens, Charles H, Martinez, Lisa, Gaziano, J Michael, Pfeffer, Marc A, Biglione, Bianca, Gitin, Alexander, McCabe, Jeanne Bell, Cook, Thomas D, DeMets, David L, Wood, Sarah K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710906/
https://www.ncbi.nlm.nih.gov/pubmed/34952844
http://dx.doi.org/10.1136/fmch-2021-001475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710906/
https://www.ncbi.nlm.nih.gov/pubmed/34952844
http://dx.doi.org/10.1136/fmch-2021-001475

Ejemplares similares